April 8, 2024
CAR TCR Summit: Myrio Tx shares transformational approach to targeted human antibody-based therapies
Myrio Therapeutics (Myrio Tx) is driving a new frontier of antibody-based therapies as the company’s Retained DisplayTM (ReD) antibody platform offers identification of highly specific human antibodies that […]